AMAG Pharmaceuticals launches IntrarosaTM (prasterone) in the U.S.
AMAG Pharma announced the commercial availability of Intrarosa™ (prasterone) at pharmacies nationwide, supported by a newly created 137-person women’s health sales force. Intrarosa is the first and only FDA-approved, local non-estrogen product for the treatment of moderate to severe dyspareunia. July 24, 2017